Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms
Clinical trial NCT01164475 · COMPLETED
Trial details
- NCT number
- NCT01164475
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2013-02-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.